Blocking a protein that imports lactic acid, a metabolic byproduct of cancer cells, reinvigorated exhausted T cells and led to improved tumor control in mouse models of cancer, according to a new study that describes how shutting off T cell access to inhibitory metabolites could be a promising new approach to cancer immunotherapy.